Cargando…
Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes
The maintenance of glucose homeostasis is fundamental for survival and health. Diabetes develops when glucose homeostasis fails. Type 2 diabetes (T2D) is characterized by insulin resistance and pancreatic β-cell failure. The failure of β-cells to compensate for insulin resistance results in hypergly...
Autores principales: | Son, Jinsook, Accili, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474037/ https://www.ncbi.nlm.nih.gov/pubmed/37524865 http://dx.doi.org/10.1038/s12276-023-01043-8 |
Ejemplares similares
-
Pair Feeding, but Not Insulin, Phloridzin, or Rosiglitazone Treatment, Curtails Markers of β-Cell Dedifferentiation in db/db Mice
por: Ishida, Emi, et al.
Publicado: (2017) -
A Brief Review of the Mechanisms of β-Cell Dedifferentiation in Type 2 Diabetes
por: Khin, Phyu-Phyu, et al.
Publicado: (2021) -
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
por: Son, Jinsook, et al.
Publicado: (2023) -
Mesenchymal stem cells ameliorate β cell dysfunction of human type 2 diabetic islets by reversing β cell dedifferentiation
por: Wang, Le, et al.
Publicado: (2020) -
CD81 marks immature and dedifferentiated pancreatic β-cells
por: Salinno, Ciro, et al.
Publicado: (2021)